Zidovudine
NDC 67046-1613, Zidovudine, tablet, from Coupler LLC.
- Product NDC
- 67046-1613
- Status
- Listed
- Labeler
- Coupler LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090092
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67046-1613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZIDOVUDINE300 mg/1
Pharmacologic classes
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67046-1613-3 | 67046161303 | 30 TABLET in 1 BLISTER PACK (67046-1613-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/437f55b2-f6d9-0065-e063-6294a90ab929
Use it
Look up 67046-1613 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67046-1613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67046-1613. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.